June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Retinal blood flow levels measured by Laser Speckle Flowgraphy in central retinal vein occlusion as a predictive factor for ischemia and visual loss
Author Affiliations & Notes
  • Makiko Matsumoto
    Ophthalmology, Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
  • Kiyoshi Suzuma
    Ophthalmology, Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
  • Yoshihisa Yamada
    Ophthalmology, Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
  • Eiko Tsuiki
    Ophthalmology, Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
  • Azusa Fujikawa
    Ophthalmology, Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
  • Takashi Kitaoka
    Ophthalmology, Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
  • Footnotes
    Commercial Relationships Makiko Matsumoto, None; Kiyoshi Suzuma, None; Yoshihisa Yamada, None; Eiko Tsuiki, None; Azusa Fujikawa, None; Takashi Kitaoka, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5126. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Makiko Matsumoto, Kiyoshi Suzuma, Yoshihisa Yamada, Eiko Tsuiki, Azusa Fujikawa, Takashi Kitaoka; Retinal blood flow levels measured by Laser Speckle Flowgraphy in central retinal vein occlusion as a predictive factor for ischemia and visual loss. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5126.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To investigate the prognosis factor for ischemia and decline in visual acuity after intravitreal bevacizumab injections (IVB) for macular edema (ME) secondary to central retinal vein occlusion (CRVO).

Methods: Thirty-one patients (31 eyes) being treated with IVB (1.25 mg/0.05 ml) for secondary ME of CRVO were examined. The patients did not have other ocular conditions that could affect retinal blood flow. They were classified according to fluorescein angiography into non- ischemic type or ischemic type. LSFG analyses of retinal blood flow levels were based on examinations of the mean blur rate (MBR) at the major vessels of the optic disc. We evaluated the rate of MBR (affected eye/ fellow eye×100, %).

Results: At the last visit, of 31 eyes, 25 (80.6%) were classified as non-ischemic types and 6 (19.4%) were classified as ischemic type. Before the first IVB, the mean logMAR visual acuity was 0.60+/-0.35% in non-ischemic group, and 1.56+/-0.58% in ischemic group, in non-ischemic group of visual acuity was significantly better than in ischemic group (P=0.00002). Before the first IVB, the mean rate of MBR was 59.8+/-23.2% in non-ischemic group, and 31.6+/-6.5% in ischemic group, in non-ischemic group of the rate of MBR was significantly greater than in ischemic group (P=0.004). Multiple linear regression analysis showed the logMAR visual acuity after the first IVB significantly correlated to the logMAR visual acuity at the last visit (Standardized coefficients: 0.67, P=0.000…). The rate of MBR after the first IVB significantly correlated to the rate of MBR to fellow eye of affected eye at the last visit (Standardized coefficients: 0.53, P=0.0016).

Conclusions: Even though the background for CRVO pathology can vary, LSFG may be useful to evaluate the degree of ischemia. The logMAR visual acuity and the rate of MBR to fellow eye of affected eye can be predictive factors in CRVO patients treated with IVB.

Keywords: 749 vascular occlusion/vascular occlusive disease • 572 ischemia • 700 retinal neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×